To better understand the underlying mechanism of the reductions in BCL-2 and MCL-1, Western blotting was performed, and the results showed that the reductions in the MCL-1 protein levels in AML cell lines treated with HHT might be mediated through proteasome degradation. Here, BCL2 is linked to acute myeloid leukemia.